Methyl 3-Fluorobenzoate | CAS:455-68-5

We serve Methyl 3-Fluorobenzoate CAS:455-68-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Methyl 3-Fluorobenzoate

Chemical Name:Methyl 3-Fluorobenzoate
CAS.NO:455-68-5
Synonyms:Methyl 3-Fluorobenzoate
3-Fluorobenzoic Acid Methyl Ester
Molecular Formula:C8H7FO2
Molecular Weight:154.13800
 
Physical and Chemical Properties:
Density:1.171
Melting point:ºC
Boiling point:197.6ºC
Flash point:71.6ºC
Index of Refraction:1.489
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like Methyl 3-Fluorobenzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Fluorobenzoic Acid Methyl Ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 3-Fluorobenzoate Use and application,Methyl 3-Fluorobenzoate technical grade,usp/ep/jp grade.


Related News: The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819.2,4-Bis(phenylsulfonyl)phenol manufacturer If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid supplier If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.3-Bromoaniline vendor Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.